| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |